ARTICLE | Company News
Alkermes pulmonary deal with Glaxo
February 3, 2000 8:00 AM UTC
GLXO received a license to ALKS's AIR pulmonary drug delivery technology for use in four respiratory disease indications. GLXO will have exclusive worldwide rights to products from the collaboration a...